VSTM:NASDAQ
Verastem Inc
$10.04
arrow_downward
-0.20%(-0.020) 1D
$10.00
arrow_downward
-0.40% (-0.040)bedtimeAfter hours
Closed: Oct 23, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VSTM...
Open
$10.08
High
$10.22
Low
$9.71
Mkt. cap
1.22B
Avg. vol.
4.36M
Volume
3.76M
52-wk high
$10.82
52-wk low
$3.43
EPS
-$2.46
Beta
0.39
Shares outstanding
121.50M
No. of employees
102
Open
$10.08
High
$10.22
Low
$9.71
Mkt. cap
1.22B
Avg. vol.
4.36M
Volume
3.76M
52-wk high
$10.82
52-wk low
$3.43
EPS
-$2.46
Beta
0.39
Shares outstanding
121.50M
No. of employees
102
News stories
From web sources and news partners
Seeking Alpha
·
18 minutes ago
The S&P 500 Is At A Crossroads, That's A Buying Opportunity (SP500)
Cryptonews.net
·
1 hour ago
This S&P 500 crash signal just made a major positive U-turn
Bloomberg.com
·
6 hours ago
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
Yahoo Finance
·
4 hours ago
Dow: 3 Key Takeaways for Long-Term Investors
Profile
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
About Verastem Inc
CEOBrian Stuglik
Employees102
Founded2010
HeadquartersNeedham, Massachusetts, United States
SectorBiotechnology
Websiteverastem.com